Cann Group share purchase plan oversubscribed by $10m

Cann Group share purchase plan oversubscribed by $10m

One of the biggest names in Australia's medicinal cannabis industry has increased the size of a share purchase plan (SPP) by 62 per cent after an encouraging uptake from investors.

Following a successful $14.3 million placement including a close to 8 per cent participation from directors, Cann Group (ASX: CAN) was aiming to raise a slightly higher amount again at $15.9 million for the SPP.

But investors were more eager than expected, with application monies of $25.9 million received from 2,793 shareholders. In response the company has raised the SPP to that same amount.

This takes the recent capital raising to a total of $40.2 million. While the funds were initially slated for working capital, Cann Group CEO Peter Crock says the additional equity will strengthen Cann's position as it looks to secure external debt funding to proceed with the first stage of its Mildura expansion.

"We are extremely pleased with the confidence and support shown by our large retail shareholding base," says Crock.

"The funding secured via the capital raising places the company in a very strong financial position to continue with our growth and expansion plans over the next 12 months and beyond."

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Trade like a pro with eToro’s CopyTrader
Partner Content
Whether you’re a beginner learning the basics or simply too busy to monitor the m...
Etoro
Advertisement

Related Stories

Rokt valuation soars to $3.6 billion, company eyes Nasdaq listing

Rokt valuation soars to $3.6 billion, company eyes Nasdaq listing

Almost a year after closing the largest single venture raise in Aus...

US giant Salesforce partners with software startup Apromore after $15.3m capital raise

US giant Salesforce partners with software startup Apromore after $15.3m capital raise

Melbourne-based software startup Apromore has teamed up with Salesf...

Operative Intelligence secures $5m to tackle customer pain points with AI

Operative Intelligence secures $5m to tackle customer pain points with AI

A Melbourne-based software company using artificial intelligence (A...

Vaxxas receives $34m capital injection to advance manufacturing of needle-free vaccine

Vaxxas receives $34m capital injection to advance manufacturing of needle-free vaccine

Brisbane-based medtech Vaxxas has today announced the completion of...